Clinical Trials
10 trialsNCT01931709 2023-11-18
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
Phase NA Terminated
NCT00470574 2020-11-18
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00945061 2020-08-18
Radiation Therapy in Treating Patients With Recurrent Breast Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT01153672 2019-09-06
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Phase NA Completed
NCT01928186 2018-05-15
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer
University of Washington
Phase NA Completed
NCT00343863 2017-07-11
Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer
University of Washington
Phase NA Completed
NCT00450723 2017-02-07
Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer
University of Miami
Phase NA Completed
NCT00030823 2015-12-30
Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00828516 2013-01-17
AMWELL-SL
East and North Hertfordshire NHS Trust
Phase NA Completed